Table 1 Details of the exposure and outcome
Trait | Year | Consortium/Author | Samples | Case | Control | Sex |
|---|---|---|---|---|---|---|
731 immune phenotypes | 2020 | Orrù et al | 3757 | / | / | 57.0% female |
Ankylosing spondylitis | 2023 | FinnGen (R9) | 392,423 | 2860 | 389,563 | Mixed |
Trait | Year | Consortium/Author | Samples | Case | Control | Sex |
|---|---|---|---|---|---|---|
731 immune phenotypes | 2020 | Orrù et al | 3757 | / | / | 57.0% female |
Ankylosing spondylitis | 2023 | FinnGen (R9) | 392,423 | 2860 | 389,563 | Mixed |
Advances in Rheumatology